newsfilter
← Latest News
PR Newswire·

Stealth BioTherapeutics Reports Second Quarter 2021 Financial Results And Recent Business Highlights

BOSTON, Aug. 5, 2021 /PRNewswire/ -- Stealth BioTherapeutics Corp (NASDAQ:MITO), a clinical-stage biotechnology company focused on the discovery, development, and commercialization of novel therapies for diseases involving mitochondrial dysfunction, toda